$8.660
-0.856 (-9.89%)收盤時
MSLE 同業比較
In the context of the broader market, MSLE competes directly with industry leaders such as ELDN and NMRA. With a market capitalization of $183.73M, it holds a significant position in the sector. When comparing efficiency, MSLE's gross margin of N/A stands against ELDN's N/A and NMRA's N/A. Such benchmarking helps identify whether Satellos Bioscience Inc. is trading at a premium or discount relative to its financial performance.
Satellos Bioscience Inc 財務表現
Satellos has been experiencing significant net losses, with the latest reported net income of -11,718,000 USD for Q2 2026. The company has a current ratio of 11.22, indicating strong liquidity, but the overall financial health is challenged by ongoing losses.
Financials
本頁僅供研究參考，不構成投資建議。模型可能出錯。過往表現不代表未來結果。